Knowledge at the heart of leadership

Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

13 Life Science Leaders to watch in 2013 – The Verdict!

Posted on January 29, 2014 by admin

Authored by Liftstream

Read the full article…

Posted in Pharmaceutical business | Tagged 13 for 13, AstraZeneca, Dalvir Gill, EFPIA, Flemming Ornskov, Foundation Medicine, Francois Nader, Gilead Sciences, James Sheppard, Jeff Leiden, Jeremy Levin, John Martin, Jorn Aldag, Karl Simpson, Karl-Ludwig Kley, Liftstream, Merck KGaA, Michael Pellini, NPS Pharmaceuticals, Pascal Soriot, Richard Bergstom, Shire, Teva, TransCelerate, uniQure, Vertex Pharmaceuticals | Leave a comment

Dr Francois Nader – NPS Pharmaceuticals – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged Dr Francois Nader, EMA, FDA, Gattex, NPS Pharmaceuticals, Orphan drugs, pricing, Rare Disease, Reimbursement, Takeda | Leave a comment

Dr John Martin – Gilead – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged Bay Area Cluster, commercial, EMA, FDA, Gilead, haematology, Hep C, HIV, John Martin, Kevin YOung, oncology, Pharmasset, share price rise, Sofosbuvir, Solvadi, YM Bioscience | Leave a comment

Mr Richard Bergstrom – EFPIA – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged ALLtrials, Bed Goldacre, Director General, EFPIA, EU, europe, Flanders Biotech, healthcare, innovative Medicine Initiative, Mr Richard Bergstom, stakeholders | Leave a comment

Dr Karl-Ludwig Kley – Merck KGaA – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged 13 for 13, AZ Electronics, BeiGene, BioRN, CEO, clinical trials, Erbitux, executive, INSPIRE, Karl-Ludwig Kley, Liftstream, Merck KGaA, Merck Serono, restructuring, Stimuvax | Leave a comment

Dr Jeff Leiden – Vertex Pharmaceuticals – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged 13 for 13, Boston Biotech, Cystic Fibrosis, Hep C, investors, Janssen, Jeff Leiden, Kalydeco, Karl Simpson, share price, vertex, Vertex Pharmaceuticals | Leave a comment

Dr Michael Pellini – Foundation Medicine – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged 13 for 13 Liftstream, biotech, Boston Biotech, diagnostics, Dr Michale Pellini, Foundation Medicine, investors, IPO, Karl Simpson, pharma, venture capital | Leave a comment

Dr Jeremy Levin – Teva – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged 13for13, Board of Directors, Jeremy Levin, Karl Simpson, Liftstream, Teva | Leave a comment

Dr Dalvir Gill – TransCelerate – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by James Sheppard

Read the full article…

Posted in Pharmaceutical business | Tagged 13 for 13, Astellas, Biogen IDEC, Common Clinical Trial Protocol, Dalvir Gill, Liftstream, Onyx Pharmaceuticals, stakeholders, TransCelerate | Leave a comment

Mr David Mott – NEA – Executive Leadership Series

Posted on January 29, 2014 by admin

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged Cristina Cissma, Cydan Corporation, David Mott, Karl Simpson, KLS Partners, Liftstream, NEA, New England Associates, Orphan drugs, Rare Disease | Leave a comment

Contact Us

   Head Office
Liftstream Ltd.
111 Buckingham Palace Road,
London,
SW1W 0SR
   Tel: +44 (0)20 4515 1123
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion

Registered in England No: 5009233
VAT: 843679292

Follow Us

Legal Statements

Complaints Procedure
Legal Notice
Privacy Policy

Site by SMXi